Stoke Therapeutics STOK
NASDAQ STOK
$25.68 -0.93 (-3.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Receivables (2024 - 2026)

Updated

Stoke Therapeutics' Receivables came in at $7.2 million for Q2 2026, up 61.8% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Receivables (2024 - 2026) Analysis & Trends

At the end of FY2025, Stoke Therapeutics' Receivables was $5.94 million, up 255.9% from FY2024.

  • Going back by year, Receivables was $1.67 million in FY2024.
  • The five-year range for quarterly Receivables is $1.67 million (Q4 2024) to $9.25 million (Q3 2025).
  • Business Quant data shows STOK's Receivables at $4.45 million (Q1 2026), $5.94 million (Q4 2025) and $9.25 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 Stoke Therapeutics 1.70 Bn 529.30 Mn - 7.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.20 Mn
Mar 31, 2026 4.45 Mn
Dec 31, 2025 5.94 Mn
Sep 30, 2025 9.25 Mn
Dec 31, 2024 1.67 Mn
API Access

Stoke Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=STOK&period=max&api_key=YOUR_API_KEY